JAK 1/2 inhibitor (ruxolitinib) might have a positive effect on MDSCS

Yang, J; Peng, B; Fang, S; Qian, K; Wang, H; Wen, Y; Jiao, Y; Liu, D; Dou, L

BONE MARROW TRANSPLANTATION, 2022; 57 (SUPPL 1): 212